[Erythrocyte and thrombocyte aggregation disorders in the pathogenesis of diabetic retinopathy and the potentials of disaggregation therapy].
D001241:Aspirin / Q000627:therapeutic use; D001791:Blood Platelet Disorders / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D002908:Chronic Disease; D003930:Diabetic Retinopathy / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D004903:Erythrocyte Aggregation / Q000187:drug effects; D006801:Humans; D010431:Pentoxifylline / Q000627:therapeutic use; D010974:Platelet Aggregation / Q000187:drug effects
D001241:Aspirin; D010431:Pentoxifylline
Narusheniia agregatsii éritrotsitov i trombotsitov v patogeneze diabeticheskoĭ retinopatii i vozmozhnosti dezagregiruiushcheĭ terapii.